Cellecta | GenomeWeb

Cellecta

The company aims to commercialize the platform and related services by late 2018.

Using enhancements to RT-PCR, the firm is able to detect all protein-coding genes in a single-tube multiplex reaction, reducing costs for large-scale projects.

The genetic screening firm validated the modifications with a Phase I SBIR grant from NIH and is seeking a Phase II grant to target critical protein domains.

The company said the library will be made freely available to academic and non-profit investigators through the DECIPHER Project.

Products & Services

Premium

Exiqon, Cellecta

The company will use the NCI funding to discover and validate gene targets involved in breast cancer that may affect a panel of epithelial cells involved in breast cancer.

Products & Services

Premium

Cellecta

The partners will use Ariadne’s software to combine siRNA screening data with information gleaned from scientific literature in order to develop a comprehensive database of prostate cancer-related information.

The collaboration brings together Ariadne, Cellecta, and the Roswell Park Cancer Institute to develop "a better understanding of the mechanisms of prostate cancer that result in novel targets and biomarkers."

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.